全冷冻策略能否规避晚卵泡期孕酮升高对累积活产率的影响?
本研究为多中心匹配对照回顾性分析,纳入2012-2018年942例全冷冻周期患者(471例孕酮升高,471例匹配对照)。结果显示,晚卵泡期孕酮升高不显著影响冷冻胚胎移植的累积活产率(29.3% vs 28.2%,P=0.773),也不影响胚胎冷冻率。
要点
- 晚卵泡期孕酮升高不显著降低全冷冻策略下的累积活产率
- 孕酮升高组与正常组的累积活产率分别为29.3%和28.2%,P=0.773
- 全冷冻策略可规避晚卵泡期孕酮升高对内膜容受性的不良影响
核心结论
- 在仅冷冻策略中,新鲜周期晚卵泡期孕酮升高不影响冷冻移植的累积活产率,也不影响胚胎冷冻率。
研究设计与样本
- 多中心(三个中心)匹配病例对照回顾性分析,纳入2012至2018年所有采用GnRH拮抗剂ICSI且全冷冻策略的周期。
- 共纳入942例患者,471例为孕酮升高组,471例为匹配的孕酮正常对照组;每位患者仅纳入一次。
主要发现
- 两组基线特征相似,但孕酮升高组扳机日雌二醇水平显著更高。
- 两组受精率无显著差异;孕酮升高组卵裂期冷冻胚胎数显著更多,而冷冻囊胚总数相同。
- 累积活产率在两组间无显著差异(正常组29.3% vs 孕酮升高组28.2%,P=0.773),多因素GEE回归校正混杂因素后结果一致。
关键数值与推荐
- 孕酮升高定义为扳机日孕酮水平≥1.50 ng/ml,正常对照组为<1.50 ng/ml。
- 累积活产率定义为妊娠24周后的活产分娩。
- 匹配标准为年龄(±1岁)和获卵数(±10%)。
临床怎么用
- 对于新鲜周期晚卵泡期孕酮升高的患者,采用全冷冻策略可规避孕酮升高对内膜容受性的影响,且不影响累积活产率。
- 临床决策中,若选择全冷冻策略,晚卵泡期孕酮升高不应作为取消冷冻或额外干预的理由。
局限性
- 本研究为回顾性多中心观察性研究,结果需前瞻性分析进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is late follicular elevated progesterone (LFEP) in the fresh cycle hindering cumulative live birth rates (CLBRs) when a freeze only strategy is applied? SUMMARY ANSWER: LFEP in the fresh cycle does not affect the CLBR of the frozen transfers in a freeze only approach, nor the embryo freezing rate. WHAT IS KNOWN ALREADY: Ovarian stimulation promotes the production of progesterone (P) which has been demonstrated to have a deleterious effect on IVF outcomes. While there is robust evidence that this elevation produces impaired endometrial receptivity, the impact on embryo quality remains a matter of debate. In particular, previous studies have shown that LFEP is associated with a hindered CLBR. However, most clinical insight on the effect of progesterone on embryo quality in terms of CLBRs have focused on embryo transfers performed after the fresh transfer, thus excluding the first embryo of the cohort. To be really informative on the possible detrimental effects of LFEP, evidence should be derived from freeze-all cycles where no fresh embryo transfer is performed in the presence of progesterone elevation, and the entire cohort of embryos is cryopreserved. STUDY DESIGN, SIZE, DURATION: This was a matched case-control, multicentre (three centres), retrospective analysis including all GnRH antagonist ICSI cycles in which a freeze all (FA) policy of embryos on day 3/5/6 of embryonic development was applied between 2012 and 2018. A total of 942 patients (471 cases with elevated P and 471 matched controls with normal P values) were included in the analysis. Each patient was included only once. PARTICIPANTS/MATERIALS, SETTING, METHODS: The sample was divided according to the following P levels on the day of ovulation triggering: <1.50 ng/ml and ≥1.50 ng/ml. The matching of the controls was performed according to age (±1 year) and number of oocytes retrieved (±10%). The main outcome was CLBR defined as a live-born delivery after 24 weeks of gestation. MAIN RESULTS AND THE ROLE OF CHANCE: The baseline characteristics of the two groups were similar. Estradiol levels on the day of trigger were significantly higher in the elevated P group. There was no significant difference in terms of fertilisation rate between the two groups. The elevated P group had significantly more cleavage stage frozen embryos compared to the normal P group while the total number of cryopreserved blastocyst stage embryos was the same. The CLBR did not differ between the two study groups (29.3% and 28.2% in the normal versus LFEP respectively, P = 0.773), also following confounder adjustment using multivariable GEE regression analysis (accounting for age at oocyte retrieval, total dose of FSH, progesterone levels on the day of ovulation trigger, day of freezing, at least one top-quality embryo transferred and number of previous IVF cycles, as the independent variables). LIMITATIONS, REASONS FOR CAUTION: This is a multicentre observational study based on a retrospective data analysis. Better extrapolation of the results could be validated by performing a prospective analysis. WIDER IMPLICATIONS OF THE FINDINGS: This is the first study demonstrating that LFEP in the fresh cycle does not hinder CLBR of the subsequent frozen cycles in a FA approach. Thus, a FA strategy circumvents the issue of elevated P in the late follicular phase. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study. Throughout the study period and manuscript preparation, authors were supported by departmental funds from: Centre for Reproductive Medicine, Brussels, Belgium; Infertility Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Centro Scienze Natalità, San Raffaele Scientific Institute, Milan, Italy; and IVI-RMA, Lisbon, Portugal. E.S. has competing interests with Ferring, Merck-Serono, Theramex and Gedeon-Richter outside the submitted work. E.P. reports grants from Ferring, grants and personal fees from Merck-Serono, grants and personal fees from MSD and grants from IBSA outside the submitted work. All the other authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Racca A, Vanni VS, Somigliana E, et al. Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles. Hum Reprod. 2021. PMID: 34223890. doi:10.1093/humrep/deab160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。